11:30pm (EST)
1. Market Summary
2. Epocrates (EPOC) – A Play on Mobile HealthCare
3. Earnings
4. Weekly Wrap Portfolio Update
5. Week Ahead
(To view the charts, please log into the Members Area and go to the Weekly Wrap Premium section.)
= = = = = = = = = = = = = = =
1. Market Summary
“The market has another week of August before September rolls around and it is usually the most bearish month of the year according to the history books. August also has some bearishness to it but so far the market is up for the month. Last week’s charts for the major indexes and the VIX showed an almost certain test to the 52-week highs and while the S&P 500 technically cleared this level, there was no “fluff” to new highs.
A pullback following a test of the 52-week high is a normal market or stock reaction. The current market is so technical and is falling right on the support and resistance lines we have outlined that we should get a really good read on a possible breakout or breakdown. We went on record last week and said the market could move 5% in September and 10% by year-end up or down depending on the headlines.
The targets we gave were Dow 14,000 or 12,600 in September followed by 14,500-14,600 or 12,000 by year-end. The S&P could be at 1,500 or 1,350 next month which would lead to 1,550 or 1,275 by Thanksgiving/ Christmas. The Nasdaq could push 3,225-3,250 or 2,925-2,900 in September and then 3,375-3,400 or 2,800-2,775 on continued strength or weakness.
There will be a ton of speculation on what Ben Bernanke might or might not do or say this Friday and over the weekend when the central bankers get together in Jackson Hole. The zombies still seem split on if another round of quantitative easing will really work and we have said how the Fed only has one bullet left.
People seem to forget that extending “Operation Twist” and the extended bond buying before that by the Fed was actually QE3 and QE4 so any new stimulus by our count would be QE5. Nothing is working and the comments from James Bullard last Thursday, a member of the FOMC, rehashed how little impact these programs have had. Yes, the first QE worked well most would agree but the real problem is the world governments want growth but growth is slowing and consumers are cutting back.
Perhaps a “saving of the euro” and another round of QE will take the market to new highs but there are so many storm clouds ahead that it is imperative we keep our eyes on the road and our hands upon the wheel. We will continue to roll with the bulls and have a real good time but be ready for a trend change if Big Ben lets the market down and Europe kicks the can off the road and into a ditch.” (from 8/26/2012 Weekly Wrap/ Monday Morning Outlook)…
The bears had the weekly edge heading into Friday’s “Black Hole” as the Dow was down 158 points; the S&P 500 a dirty dozen; and the Nasdaq was off by a hand of blackjack. The support targets we gave last week held like a rock and Friday’s rebound was a direct result of Ben Bernanke promising more quantitative easing. Although it wasn’t enough to win the week, the bulls won August and could have a September to remember if Europe delivers some good news this week.
The Dow gained 90 points, or 0.7%, to finish at 13,090 on Friday. The blue-chips traded in a tight range until Thursday’s dip to 12,978 but held support at 13,000 on the close. Friday’s high of 13,151 was also the peak for the week. The bulls will try to push 13,200 and then 13,350 this week while the bears will target 12,800 and the 100-day MA again. The Dow started Monday at 13,158 and fell 68 points, or 0.5%, for the week. For the year, the blue-chips are higher by 873 points, or 7.2%, following the 0.6% pop in August.
Here is last week’s chart for the Dow:
The S&P 500 advanced 7 points, or 0.5%, to end at 1,406. The index tested a low of 1,397 on Thursday’s pullback and closed below the 1,400 level (by a half-point) which has been strong short-term support. There is still risk to 1,375 and possibly 1,350 if Europe fails to impress Wall Street and the Fed doesn’t ease. The bulls are still shooting for a close above 1,425 so that they can mount an assault on 1,450. The S&P 500 came into the week at 1,411 and slipped 5 points, or 0.3%, by Friday’s close. For 2012, the index is up 149 points, or 11.9%, after posting a 1.9% gain in August.
The S&P 500 chart from last week:
The Nasdaq jumped 18 points, or 0.6%, to settle at 3,067. We have been mentioning the 3,050 level as strong short-term support which was tested last week on Thursday’s close of 3,048. The index tested 3,040 on Friday which still keeps 3,025-3,000 in the mix. If the Nasdaq closes above 3,075, there could be another run to 3,100 which has been a brick wall for the bulls, but, a close above this level would get 3,150 in play. The Nasdaq was at 3,069 before Monday’s opening bell and gave back 2 points, or 0.1%, for the week. YTD, the index has surged 462 points, or 17.7%, and was up 4.3% in August.
Here is the chart for the Nasdaq from last week:
The Russell 2000 added 3 points, or 0.4%, to close at 812. The small-caps reclaimed the 810 level after closing at 809 on Thursday. Friday’s low of 805 was still a reminder on how close the index is from tripping 800 and possibly 780 on a bad headline. The bulls will attempt to clear and close above 820 and could attack 830 if Europe does all in can to save the euro. The Russell 2000 was at 809 to begin the week and made a surprise gain of 3 points, or 0.4%, before the 3-day weekend hit. For the 8 months just ended, the Russell 2000 is up 72 points, or 9.6%, after advancing 2% in August.
Here is how the chart for the Russell 2000 looked last week:
The S&P Volatility Index ($VIX, 17.46, down 0.36) is getting more volatile like we have been warning and closed just below the 17.50 level on Friday. The VIX closed higher every day and tripped 18 before Friday’s slight drop. We said a close above 17.50 could get Wall Street’s panties in a knot and 20 could signal a trend change. A move back below 15 would be bullish and a sign the bulls could push new highs for the year.
Here is VIX chart from last week:
We factored in a possible 1%-2% move for the market on Friday based on what Bernanke did or didn’t say and at one-point the indexes were up nearly 1.5%. There was plenty of volatility at the open and once the fireworks began but the trend was higher once Big Ben said the Fed WILL print more money, we mean, provide more stimulus.
Here is the money sentence that gave the bulls the green light:
“Taking due account to the uncertainties and limits of its policy tools, the Federal Reserve will provide additional policy accommodation as needed to promote a stronger economic recovery and sustained improvement in labor market conditions in a context of price stability.” (END)
The knee jerk reaction was expected but Big Ben basically checked the pot back to Mario Draghi which gave him two more weeks to see what Europe does. The Fed and its members should be mum until they meet again on September 12 as there is technically a week-long blackout period ahead of the meeting.
Draghi has cried wolf more times than we care to count and he will take center stage again on Thursday (September 6) as the European Central Bank (ECB) meets. The market is expecting the ECB to announce some kind of bond-buying program but there is, believe it or not, a chance they delay an announcement until next week on September 12 which is when Germany is expected to vote on the European Stability Mechanism (ESM).
To review, the ESM provides “financial assistance”, or bailouts, to the members of the eurozone who need financial aid. We have mentioned all summer long Germany has grown tired of flipping the bills for the struggling counties like Greece and Spain and is expected to vote on the treaties that were established for the fund. Back in July, a German court looked into the complaints of the constitutionality of the ESM and this vote could be crucial in if the euro gets saved or not. If Germany does give the okay for the ESM to establish a permanent bailout fund, the markets should rally, but again, this news isn’t expected until next week although there has been a leak. Germany’s Finance Minister, Wolfgang Schaeuble, has gone on record saying that he does not see the Constitutional Court blocking the established treaties so Draghi could be safe if he gives the market something to nibble on.
The Dow Transportation Average showed signs of life on Friday and will need to break out of its downtrend if the bulls expect to test new highs. The index trended lower all summer before the August bounce and pullback which is in danger of falling below the uptrend line. A close below 4,950 on the Dow Transports could spell lights out for the bulls. A close above 5,050 would be bullish.
Commodities also made a nice move and we mentioned midweek gold and silver were on the verge of breaking out:
This week has the potential to be bullish as the charts favor the bulls. The Tuesday after Labor Day is usually bullish and it is the first trading day of the month. With the suit-and-ties coming off their August vacations, they will be anxious, or forced, to buy stocks if the market gets off to a strong start and the rally resumes.
There are several U.S. economic reports slated for the week with Friday’s Nonfarm Payroll report and Unemployment numbers which could help or hinder any momentum. This week’s headlines will likely get the market back at resistance or short-term support. This means the indexes would again be at crucial levels heading into the following week which will also be packed with Tech news.
We may take a few directional trades this week for our Daily and there a couple of covered call positions for our Weekly Wrap that we may trade but we don’t need to force the action. Although we have done well navigating the rocky waters, this is still a treacherous market to trade so please keep this in mind until we establish a clear trend.
As we head to press, futures are showing a slightly higher open for Tuesday. Dow futures are up 26 points to 13,105 while the S&P 500 futures are higher by 3 points to 1,408. The Nasdaq 100 futures are advancing 10 points to 2,781.
= = = = = = = = = = = = = = =
Key of Technicals Used In Following Articles
2. Epocrates (EPOC) – A Play on Mobile HealthCare
By Michael Bryant
Epocrates (EPOC, $8.92, up $0.16) has been in a near free-fall since its February 2011 IPO, plunging from a high of $25.77 to current levels. Shares are down 65% since it became a publicly-traded company and it is time to see if shares are nearing a bottom as a possible good entry point.
The company is named as a combination of e-communications and Hippocrates, the ancient Greek physician who inspired the Hippocratic Oath. It is believed 98% of American medical students swear some form of the oath, which requires a new physician to swear to practice medicine ethically and honestly.
Content is not proprietary and is presented in a way easy to use. To access the company’s free database, a user must register with name, email, username, password, and occupation. From there, you can purchase premium products, like those for Apple iOS shown below.
In 2008, the firm was approached by Goldman Sachs and ended up striking a deal in which Goldman Sachs bought 13% of the company. It allowed Goldman Sachs to sell its market research technology to hedge funds and Wall Street. A hedge fund looking at Merck as an investment could go out to a bunch of doctors and get their opinion on the new drugs.
In 2009, the drug industry spent $14 billion a year to influence people who prescribe drugs. Representatives would go to each office to tell the doctors about the drugs but doctors either only had a few minutes to see the representatives or would not allow the representatives to see them. Thus, a new way of reaching the doctors was needed.
The market opportunity for how much physicians and health care professionals would spend for software and reference materials was only $400 million, much smaller than the $14 billion the drug industry paid. Thus the company decided to give their database for free or for a very low price and develop communication tools for the pharmaceutical industry to reach doctors.
Since doctors do not like to look at spam and the company wanted to keep doctors’ trust, it only allowed advertisements relevant to the doctors. For example, if Pfizer wanted to promote a message about Lipitor to cardiologists, then they needed to add a study that the New England Journal of Medicine published that talked about the effectiveness of Lipitor versus Crestor.
Ranked as #1 among the industry’s most used mobile drug reference, many top medical schools, such as Yale School of Medicine and Drexel University College of Medicine, recommend or require students to have a mobile device loaded with Epocrates app. Its Essentials subscription for drug, disease, and diagnosis reference costs $159 but is free for medical students. By doing things this way, the company is investing in the future in medicine as well as gaining loyal users.
On Thursday, September 13th, Epocrates will hold the 7th annual Future Physicians of America Survey at 2:00 p.m. ET. The meeting will address insights including: opinions about healthcare reform and legislation, future career goals and expectations, mobile technology usage, and clinical training strengths and weaknesses. Last year’s survey highlighted four apps used most by medical students: Epocrates, Medscape, UpToDate, and Skyscape. It also showed that the majority of medical students use mobile devices, primarily Apple’s iPhone, to access drug and safety information in real time, and many students use Epocrates.
In 2005, unaudited revenue was nearly $34.7 million, up from $10 million in 2003. By 2008, revenues were $65 million. The bulk of that revenue came from advertising. Users must click through messages and alerts from drug companies before they can access its drug information. It also sends alerts covering studies from leading medical journals, new treatment options and news from the Food and Drug Administration and other government agencies. The company also makes money by doing market research.
Epocrates reported 2nd quarter earnings in August that beat expectations. Revenue came in at $26.8 million, above estimates of $25.8 million. Non-GAAP earnings came in $0.03 per share, above estimates of $0.01. However, GAAP earnings per share were -$0.02 compared to $0.13 per share a year ago. Sales were 3.7% lower than the $27.9 million in sales a year ago. Analysts expect 3rd quarter earnings of $0.01 per share on revenue of $25.8 million.
Total expenses seem to be climbing faster than revenue. Plus, subscription revenue is falling. If subscription revenue continues to decline and interactive services revenue (mainly advertising) cannot make up the difference, the company could fall into a trap. However, it seems Epocrates can beat estimates for the upcoming quarter from the graphs below.
At $8.92, the stock is between its mean target of $10.50 and low target of $6.00 made by the 4 analysts recorded by Thomson/First Call. Median target is $11.50, and high target is $13.00. Using a scale of 1.0 as a strong buy and 5.0 as a sell, the average rating of the stock was 2.8, unchanged from a week ago.
|
|
Current Month |
Last Month |
Two Months Ago |
Three Months Ago |
|
Strong Buy |
0 |
0 |
0 |
0 |
|
Buy |
2 |
2 |
2 |
2 |
|
Hold |
3 |
3 |
3 |
3 |
|
Underperform |
1 |
1 |
1 |
0 |
|
Sell |
0 |
0 |
0 |
0 |
= = = = = = = = = = = = = = =
3. Earnings
The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter. If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week (Quotes are from 8/31/12 close)
By Catherine Tierney
Tuesday
Calavo Growers (CVGW, $26.20, down $0.97), Campbell Soup (CPB, $35.09, down $0.26), Comverse Technology (CMVT, $6.04, down $0.10), Evolution Petroleum (EPM, $7.86, down $0.15), Finisar (FNSR, $13.95, down $1.46), Francesca’s Holdings (FRAN, $35.74, down $0.54), Guidewire Software (GWRE, $28.09, down $0.29), Hooker Furniture (HOFT, $11.43, down $0.27), Pep Boys – Manny, Moe & Jack (PBY, $8.99, down $0.20), Perceptron (PRCP, $5.10, down $0.02), Quanex Building Products (NX, $17.50, down $0.17), Smithfield Foods (SFD, $19.10, down $0.16), Sycamore Networks (SCMR, $14.77, down), Teavana (TEA, $11.37, down $0.25)
Wednesday
ABM Industries (ABM, $20.18, down $0.18), AeroVironment (AVAV, $23.38, down $0.61), Conns (CONN, $22.30, down $0.37), Credo Petroleum (CRED, $14.46, down $0.01), Daxor (DXR, $8.96, Flat), Delta Apparel (DLA, $14.14, down $0.11), Dollar General (DG, $50.07, up $1.53), G-III Apparel (GIII, $31.01, down $0.76), H&R Block (HRB, $16.55, up $0.21), Korn/Ferry (KFY, $14.37, down $0.23), Matrix Service (MTRX, $11.51, down $0.37), Mediware Information (MEDW, $14.60, down $0.03), The Men’s Wearhouse (MW, $31.39, down $0.44), Mitcham Industries (MIND, $14.66, down $0.82), NCI Building (NCS, $10.74, down $0.18), Pike Electric (PIKE, $8.78, down $0.30), SeaChange (SEAC, $8.11, Flat), Sigma Designs (SIGM, $6.90, down $0.20), Stewart Enterprises (STEI, $7.38, Flat), SWS (SWS, $5.58, down $0.40), VeriFone Systems (PAY, $34.55, down $0.11), Verint (VRNT, $28.61, down $0.25)
Thursday
Accuray (ARAY, $6.12, down $0.12), Aceto (ACET, $8.75, up $0.12), AEP Industries (AEPI, $50.09, up $0.14), Bazaarvoice (BV, $14.35, up $0.08), Cherokee (CHKE, $13.11, up $0.14), Cooper (COO, $83.16, down $0.07), Infoblox (BLOX, $21.76, up $0.11), Layne Christensen (LAYN, $20.05, down $0.51), Mattress Firm (MFRM, $32.06, up $1.17), Met-Pro (MPR, $9.10, down $0.09), National Beverage (FIZZ, $14.67, down $0.27), Smith & Wesson (SWHC, $8.06, down $0.09), Sparton (SPA, $10.00, Flat), Triangle Petroleum (TPLM, $6.71, down $0.11), Ultra Salon Cosmetics & Fragrance (ULTA, $93.63, down $0.70), UTi Worldwide (UTIW, $13.63, down $0.06)
Friday
ALCO Stores (ALCS, $6.55, down $0.11), Brady (BRC, $28.07, down $0.33), Casey’s General Stores (CASY, $56.80, down $0.20), Kroger (KR, $22.20, up $0.05)
= = = = = = = = = = = = = = =
4. Weekly Wrap Covered Call Portfolio Update (Closing prices as of 8/31/12)
Closed Trades for 2012 (22-0, overall): ARNA +117%, SZYM +11%, BAC +26%, EFTC +8%, SZYM +55%, VVUS +38%, CALL +19%, BAC +20%, SYMC +16%, DAR +20%,TIVO +5%, MGM +22%, ZNGA+13%, SGMS +6%, VVUS +17%, F +8%, AA +7%, CLNE +27%, DNDN +18%, MGM +19%, ACAS +3%, P +9%.
Solazyme (SZYM, $11.99, down $0.02)
September 12.50 calls (SZYM120922C00012500, $0.30, down $0.05)
Original Entry Price: $12.35 (8/9/12)
Lowered Price from Selling Options: $11.55
Exit Target: $15+
Return: 4%
Stop Target: $9
Action: We mentioned last week there could be risk down to $12.50 and the close below this level midweek puts $11 back in play. From there, a trip to $10.50 is possible as the close below the 100, 200 and 50-day MA’s last week wasn’t pretty. Shares will need to reclaim prior resistance at $12.50 to reestablish the bullish trend.
We recommended buying the stock at $12.35 on 8/9/2012 and for every 100 shares to sell the September 12.50 calls for 80 cents. This lowered the cost basis to $21.75.
If we are called away in mid-September at $12.50 the trade will make 8%.
Vivus (VVUS, $21.45, down $0.06)
Original Entry Price: $22.70 (7/27/12)
Lowered Price from Selling Options: $21.75
Exit Target: $30+
Return: -1%
Stop Target: $15
Action: Shares traded up $22.34 on at the beginning of the week while the low was $21.60. We were hoping $22 would hold as it would signal a move to $24 and where we would like to sell another option. There is still risk down to $20 and the chart is showing a possible big move is coming either way.
We are looking at selling the September 22 calls (VVUS120922C00021000, $0.85, down $0.05) but that would cap our gains at $22 and we don’t want to get called away too early. The September 23’s are going for 50 cents and we are watching them as well. Our 2013 price target for Vivus is $50-$60 so we don’t mind holding the stock while we wait for better prices.
We recommended buying the stock at $22.70 on 7/27/2012 and for every 100 shares to sell the August 24 calls for 95 cents. This lowered the cost basis to $21.75.
Antares Pharma (ATRS, $3.88, flat)
Original Entry Price: $4.94 (7/13/12)
Lowered Price from Selling Options: $4.24
Exit Target: $8+
Return: -8%
Stop Target: None
Action: Shares traded up to $4.09 to start the week and Friday’s print of $3.81 was the low. Resistance is at $4.10 and support at $3.60 has formed a tight range and a close above the 50-day MA would be super bullish. The November 5 calls (ATRS121117C00005000) closed at 30 cents on Friday and we may target them this week to sell against our position.
We recommended buying the stock at $4.94 on 7/13/2012 and for every 100 shares to sell the August 5 calls for 70 cents. This lowered the cost basis to $4.24.
Antares Pharma (ATRS, $$4.00, up $0.09)
February (2013) 7.50 calls (ATRS130216C0007500, $0.30, flat)
Original Entry Price: $0.80 (7/13/12)
Exit Target: $1.60
Return: -63%
Stop Target: None
Action: This is a LEAP call option which has nearly 6 months before expiration. We have a target of $8-$10 for the stock which is a strong takeover candidate.
Bank of America (BAC, $8.16, flat)
Original Entry Price: $8.93 (4/17/12)
Lowered Price from Selling Options and Dividends: $8.24
Exit Target: $15+
Return: -3%
Stop Target: None
Action: BofA fell below $8 on Tuesday and traded down to $7.83 on Thursday. Short-term support is at $7.80 and then $7.50 and the 200-day MA. Resistance is at $8.40. The October 8 calls (BAC121020C00008000, $0.42, up $0.03) would lower our cost basis to under $8 but we are waiting for shares to push $9 before selling another call option.
We recommended buying the stock at $8.93 on 4/17/2012 and for every 100 shares to sell the May 9 calls for 45 cents. This lowered the cost basis to $8.48.
On 5/30/12 the company paid a 1 cent quarterly dividend which lowered our cost basis to $8.47.
On 6/19/12 we sold the August 9 calls for 23 cents to lower our cost basis to $8.24.
Pizza Inn (PZZI, $3.44, up $0.12)
Original Entry Price: $4.50 (2/22/12)
Lowered Price from Selling Options: No options listed (yet)
Exit Target: $9
Return: -24%
Stop Target: None
Action: Pizza Inn continues to open new pie shops in Texas. The company’s latest restaurant on the University of Texas campus was its seventh location with an eighth planned in Allen, Texas.
Shares traded down to $3.12 to start the week but held $3.27 for 3-straight days which could be forming as new short-term support, up from $3. We said resistance at $3.50 would be strong and a close above this level would get $3.75-$4 back on the map.
The company recently won the prestigious 2012 Hot Concepts award from the Nation’s Restaurant News and the buzz is growing. The company is targeting 75 major cities to expand and some will be company owned or franchised. Insiders are buying shares at these low levels and we feel you should be loading up too while they are still under $4. We have a 12 to 18-month price target of $10 for Pizza Inn.
MGM Resorts (MGM, $9.86, up $0.03)
Original Entry Price: $13.77 (2/2/12)
Lowered Price from Selling Options: $12.67
Exit Target: $15
Return: -22%
Stop Target: None
Action: Shares held $10 all week until Thursday’s dip to $9.80 and the close at $9.83. We said if $10 failed, $9.50 would serve as backup support. The high on Friday was $10.12 and a close back above double-digits could get $11 back in play.
We recommended buying the stock at $13.77 on 2/2/2012 and for every 100 shares to sell the March 15 calls for 45 cents. This lowered the cost basis to $13.32.
On 3/20/12 we recommended selling the April 14 calls for $0.65 which lowered the cost basis to $12.67.
Alcoa (AA, $8.56, up $0.12)
Original Entry Price: $9.65 (1/12/12)
Lowered Price from Selling Options and Dividends: $8.73
Exit Target: $11
Return: -2%
Stop Target: None
Action: Following a brief run at resistance the prior week, which is at $9, shares tested a low of $8.39 which is just below the 50-day MA. Further support lies at $8.40. We would like to see a run back to $9 or even $8.75 which is where we will sell another call or exit with a slight profit to move on to another, faster-moving, trade.
We recommended buying the stock at $9.65 on 1/12/12.
On 1/23/12 we recommended selling the March 11 calls for $0.25 which lowered the cost basis to $9.40.
On 2/1/12 the company paid a 3 cent dividend which lowered our cost basis to $9.37.
On 3/20/12 we recommended selling the April 11 calls for $0.20 which lowered the cost basis to $9.17.
On 5/10/12 the company paid a 3 cent quarterly dividend which lowered our cost basis to $9.14.
On 6/19/12 we sold the August 9 calls for 38 cents to lower our cost basis to $8.76. If shares are called away in mid-August at $9 the trade will make 3%.
On 8/1/12 the company paid a 3 cent dividend which lowered our cost basis to $8.73.
Newpark Resources (NR, $6.88, up $0.12)
Original Entry Price: $9.45 (7/27/11)
Lowered Price from Selling Options: $7.85
Exit Target: $11
Return: -12%
Stop Target: None
Action: Newpark failed to hold $7 and could test $6.60 on further weakness. A close above $7.20 would be bullish.
We recommended buying the stock at $9.45 on 7/27/2011 and for every 100 shares to sell the August 10 calls for 50 cents. This lowered the cost basis to $8.95.
On 9/15/2011 we recommended selling the December 10 calls for $0.85 which lowered the cost basis to $8.10.
On 1/25/2012 we recommended selling the March 12.50 calls for $0.25 which lowered the cost basis to $7.85.
Trades on HOLD: DryShips (DRYS, $2.19, down $0.01), AKS Steel Holding (AKS, $5.22, up $0.22), Rare Element Resources (REE, $3.93, up $0.03), Rambus (RMBS, $4.28, down $0.03), Patriot Coal (PCXCQ, $0.15, down $0.01), OCZ Technology Group (OCZ, $5.66, up $0.07), Bebe Stores (BEBE, $5.43, up $0.03), Scientific Games (SGMS, $7.33, up $0.08)
= = = = = = = = = = = = = = =
5. Week Ahead
With the market being closed on Monday, it means more information will be packed-in the 4 days of trading we have left for the week.
Tuesday kicks off with the ISM Index and Construction Spending reports at 10am (EST) followed by Auto and Truck Sales later in the day at 2pm.
Wednesday action will consist of the MBA Mortgage Index which will be released at 7am followed by the Productivity and Unit Labor Costs numbers at 8:30am.
Thursday will be all about the employment numbers as Challenger Jobs Cuts (7:30am), ADP Employment Change (8:15am) and Initial/ Continuing Claims (8:30am) are all due out before the opening bell. At 10am, ISM Services will hit the Street, followed by the weekly Crude Inventories update at 11am.
We wrap up the week with Nonfarm Payrolls on Friday at 8:30am. The Unemployment Rate, Hourly Earnings, Average Workweek, and Nonfarm Private Payrolls figures are also due out an hour before the bell.



























